As03b-H7n9 Vaccine Clinical Study
Contract Overview
Contract Amount: $18,161,554 ($18.2M)
Contractor: Glaxosmithkline, LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2019-08-28
End Date: 2024-04-29
Contract Duration: 1,706 days
Daily Burn Rate: $10.6K/day
Official Description: AS03B-H7N9 VACCINE CLINICAL STUDY
Place of Performance
Location: North Carolina, 27709